Walking Tall app for home-based gait training in Parkinson's disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This open-label, single-arm pilot will recruit 30 people with idiopathic Parkinson's disease who are enrolled in a rehab program at the Ezra LeMarpe Organization in Israel. Participants will use the Walking Tall smartphone app for 4–5 walking sessions per week over six weeks; the app provides rhythmic auditory cues and motivational verbal prompts to encourage faster, longer steps and greater walking confidence. Daily walking duration and step counts are the primary outcomes measured by a wearable tri-axial accelerometer worn for seven days at baseline and post-intervention, with secondary measures including gait speed, balance, self-reported confidence, and app usability. Findings will focus on feasibility, adherence, and preliminary changes in walking behavior to guide future randomized trials.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Clinical diagnosis of idiopathic Parkinson's disease (MDS criteria);
* Hoehn \& Yahr stage II-III (ON-medication state);
* Able to walk independently for ≥5 minutes;
* Stable medication for ≥1 month;
* Currently enrolled in a rehab program at Ezra LeMarpe;
* Able to provide written informed consent;

Exclusion Criteria:

* Musculoskeletal, neurological, or visual/hearing impairments affecting gait;
* Cognitive impairments or severe behavioral symptoms;
* History of stroke, severe TBI, or brain tumor;
* Cardiovascular contraindications;
* Inability to use a smartphone;
* Participation in other concurrent intervention studies.

Where it's running

• Tel Aviv Sourasky Medical Center (Ichilov Hospital)
  Tel Aviv, Israel Recruiting

Study contacts

• Principal investigator: Tatyana Gurevich, Prof — Head of the Movement Disorders Unit at Ichilov Hospital
• Study coordinator: Marina Brozgol, MS
• Email: marinab@tlvmc.gov.il
• Phone: +972-3-6947514

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Ginger as a Modifier of Ghrelin Levels in Parkinson’s Disease and REM Sleep Behavior Disorder

  This study tests whether ginger capsules can raise ghrelin levels in people with Parkinson’s disease, REM sleep behavior disorder, and healthy controls.

  Recruiting Cambridge University Hospitals NHS Foundation Trust · Cambridge · NCT07882108

• Intraoperative Microelectrode Recordings with MAVEN vs Standard Equipment

  This study tests whether MAVEN can match the recording data collected during DBS surgery for movement disorders using standard equipment.

  Recruiting Mayo Clinic · Rochester, Minnesota · NCT07868614

• Mental imagery with self-regulation to help daily activities in Parkinson's disease

  This study tests whether a six-week program of mental imagery combined with self-regulation can help people with Parkinson’s perform daily activities better than standard learning or exercise.

  Recruiting The Hong Kong Polytechnic University · Hong Kong · NCT07860294

• Real-world experiences of Inbrija for Parkinson's OFF episodes

  This study looks at how people with Parkinson’s who use Inbrija for OFF episodes feel and function in daily life.

  Recruiting Merz Pharmaceuticals GmbH · Altmünster and 1 other locations · NCT07797790

• Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns

  This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.

  Recruiting University of Cambridge · Cambridge, CB2 · NCT07786116

• Test of RO7568282 in early Parkinson's disease

  This study tests whether RO7568282, compared with placebo, is safe and helps people with early Parkinson's disease who are already taking levodopa.

  Recruiting at 4 sites Phase 2 Hoffmann-La Roche · Boca Raton, Florida and 3 other locations · NCT07781644

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.